Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Final Mixing Tank Clean-in-Place (CIP) Operations – V 2.0

Posted on By

Elixir Department: SOP for Final Mixing Tank Clean-in-Place (CIP) Operations – V 2.0

Standard Operating Procedure for Final Mixing Tank Clean-in-Place (CIP) Operations

Department Elixir Department
SOP No. SOP/ELX/100/2025
Supersedes SOP/ELX/100/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To describe the procedure for automated Clean-in-Place (CIP) of the final mixing tank used in elixir manufacturing, ensuring effective removal of product residues and microbial contaminants.

2. Scope

This SOP is applicable to the CIP of final mixing tanks with fixed spray balls or CIP ports in the Elixir Department after batch completion and prior to the next use.

3. Responsibilities

  • Production Operator:
    • Execute CIP cycle as per protocol and monitor parameters.
    • Record observations and cleaning parameters.
  • Production Supervisor:
    • Verify tank status and review CIP records.
  • QA Officer:
    • Ensure CIP effectiveness is validated and samples are within acceptance limits.
See also  Elixir Department: SOP for Minimizing Foaming During Mixing - V 2.0

4. Accountability

The Head of Production is accountable for proper execution, validation, and documentation of all Clean-in-Place activities for final mixing tanks.

5. Procedure

5.1 Pre-CIP Checks

  1. Ensure batch transfer is complete and
the tank is declared “Empty”.
  • Close all drain valves and ensure spray balls are intact and functional.
  • Place “Under Cleaning” status label on the tank.
  • 5.2 CIP Cycle Description

    1. Pre-rinse: Use ambient temperature purified water for 5–10 minutes to remove loose residues.
    2. Detergent wash: Circulate 2% non-ionic detergent solution at 60°C for 15–20 minutes.
    3. Intermediate rinse: Rinse with purified water until detergent traces are removed (conductivity check below 1.3 μS/cm).
    4. Sanitization: Circulate 0.1% peracetic acid or 70% IPA solution for 10 minutes (if applicable).
    5. Final rinse: Rinse with purified water for 5 minutes to remove sanitizing agent.

    5.3 Monitoring Parameters

    1. Record temperature, flow rate, cycle duration, and conductivity during each CIP phase.
    2. Use automated CIP panel or manual instruments as applicable.
    3. Attach CIP Parameter Log (Annexure-1) to the BMR.

    5.4 Post-CIP Verification

    1. Visually inspect tank interior using inspection lamp and manhole access.
    2. Collect rinse water sample for microbiological and chemical residue testing.
    3. Tank shall be labeled “CLEANED” only after satisfactory QC release.

    5.5 Documentation

    1. Record each step in the CIP Checklist and Log Sheet (Annexure-2).
    2. Ensure operator and supervisor sign off on completion.
    3. Attach logs with the corresponding BMR.

    6. Abbreviations

    • CIP: Clean-in-Place
    • SOP: Standard Operating Procedure
    • BMR: Batch Manufacturing Record
    • QA: Quality Assurance
    • QC: Quality Control

    7. Documents

    1. CIP Parameter Log (Annexure-1)
    2. CIP Checklist and Log Sheet (Annexure-2)
    3. Batch Manufacturing Record (BMR)

    8. References

    • WHO TRS 986 – GMP for Pharmaceutical Products
    • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
    • ISPE Baseline Guide Vol 5 – Commissioning and Qualification

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: CIP Parameter Log

    Date Batch No. Step Temp (°C) Flow Rate (L/min) Conductivity (μS/cm) Duration (min) Operator
    11/04/2025 ELX-1039 Detergent Wash 60 80 NA 15 Rajesh Kumar

    Annexure-2: CIP Checklist and Log Sheet

    Step Completed (Yes/No) Initials Date/Time Remarks
    Pre-Rinse Yes RK 11/04/2025 09:00 –
    Detergent Cycle Yes RK 11/04/2025 09:15 –
    Final Rinse Yes RK 11/04/2025 09:45 Clear water

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Expanded steps and added sanitization option Process Optimization QA Head
    See also  Elixir Department: SOP for Intermediate Holding Studies - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Biosimilars: SOP for Seed Train Validation – V 2.0
    Next Post: Sterile Injectable Manufacturing: SOP for Prefilled Syringe Filling Machine Operation – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version